Skip to content

Effects of Ultrasound-Guided Stellate Ganglion Block Combined with Esketamine on Anxiety, Depression, and Sleep in Postpartum Women After Cesarean Section

Effects of Ultrasound-Guided Stellate Ganglion Block Combined with Esketamine on Anxiety, Depression, and Sleep in Postpartum Women After Cesarean Section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117227
Enrollment
Unknown
Registered
2026-01-21
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety, depression

Interventions

Ultrasound-guided stellate ganglion block + esketamine group:The combined analgesia regimen consisted of ultrasound-guided stellate ganglion block with 3 ml of 0.5% ropivacaine, plus a patient-control
esketamine group:Patient-controlled intravenous analgesia (PCIA) pump containing esketamine at a dose of 0.5 mg/kg

Sponsors

The Third People's Hospital of Bengbu
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 45 Years

Inclusion criteria

Inclusion criteria: ? Full-term, singleton pregnancy; ? No abnormalities in the mother or fetus detected by ultrasound; ? Indications for cesarean section; ? Age <= 45 years; ? American Society of Anesthesiologists (ASA) physical status class I–II; ? Body mass index (BMI) < 35 kg/m²; ? Normal cardiopulmonary and coagulation functions; ? Normal cognitive and communication abilities; ? Request for postoperative patient-controlled intravenous analgesia (PCIA).? Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: ? History of psychiatric disorders, drug or alcohol dependence prior to delivery; ? Comorbid with special obstetric complications or with diseases of the immune system or hematologic system; ? History of anesthesia allergy or allergy/contraindications to the drugs used in this study; ? Failure of neuraxial anesthesia; ? Intraoperative or postoperative blood loss > 800 ml.

Design outcomes

Primary

MeasureTime frame
Postpartum Depression Status;Safety and Tolerability;

Secondary

MeasureTime frame
Anxiety Status;Sleep Quality;Analgesic Efficacy and Analgesic Consumption;

Countries

China

Contacts

Public ContactLiang Cheng

The Third People's Hospital of Bengbu

bbchengliang@163.com+86 138 6503 8823

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026